Analysed GERON CORP (GERN:NASDAQ) News Sources
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026
12-05-2026
yahoo.com
Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
19-05-2026
yahoo.com
Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
01-06-2026
yahoo.com
After Plunging 26.6% in 4 Weeks, Here's Why the Trend Might Reverse for Geron (GERN)
04-06-2026
yahoo.com
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18-06-2026
yahoo.com
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14-07-2026
yahoo.com
What is the current price of GERON CORP (GERN:NASDAQ)?
The current price of GERON CORP (GERN:NASDAQ) is $1.44.
GERON CORP (GERN:NASDAQ) absolute price change since previous trading day?
The absolute price change of GERON CORP (GERN:NASDAQ) since the previous trading day is $0.02.
GERON CORP (GERN:NASDAQ) percentage price change since previous trading day?
The percentage price change of GERON CORP (GERN:NASDAQ) since the previous trading day is 1.4085%.
What is the most recent average sentiment score for GERON CORP (GERN:NASDAQ)?
The most recent average sentiment score for GERON CORP (GERN:NASDAQ) is 52 out of 100.
What is the most recent average sentiment for GERON CORP (GERN:NASDAQ)?
The most recent sentiment for GERON CORP (GERN:NASDAQ) is .
SEC-8K** Filing Available For GERON CORP (GERN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.